Showing results (1991-2000 of 2,092) with videos related to

Sort By:
Pageof 210
Photosynthesis Research|November 25, 2005
Expression profiling of metabolic genes in response to methyl jasmonate reveals regulation of genes of primary and secondary sulfur-related pathways in Arabidopsis thalianaRicarda Jost, Lothar Altschmied, Elke Bloem, et al.
Endoscopy|March 28, 2024
Influence of artificial intelligence on the diagnostic performance of endoscopists in the assessment of Barrett's esophagus: a tandem randomized and video trialMichael Meinikheim, Robert Mendel, Christoph Palm, et al.
Medrxiv : the Preprint Server for Health Sciences|February 8, 2024
Blood-based screening for HPV-associated cancersDipon Das, Shun Hirayama, Ling Aye, et al.
BMJ Open|November 28, 2020
Enhancing Prehospital Outcomes for Cardiac Arrest (EPOC) study: sequential mixed-methods study protocol in Michigan, USARama A Salhi, Sydney Fouche, Peter Mendel, et al.
Research and Reports in Urology|December 28, 2020
Treatment of Recurrent Urinary Tract Infection Symptoms with Urinary Antiseptics Containing Methenamine and Methylene Blue: Analysis of Etiology and Treatment OutcomesCarlos Romualdo Barbosa Gama, Manoel Antônio Gonçalves Pombo, Carlos Pereira Nunes, et al.
Endoscopy|February 5, 2025
Use of artificial intelligence in submucosal vessel detection during third-space endoscopyMarkus W Scheppach, Robert Mendel, Anna Muzalyova, et al.
Lancet (London, England)|March 22, 2015
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosisRodney Dawson, Andreas H Diacon, Daniel Everitt, et al.
Haematologica|July 17, 2025
Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemiaBradley Rockwell, Mendel Goldfinger, Ioannis Mantzaris, et al.
Transfusion|August 6, 2025
Adding the FcRn antagonist efgartigimod for the prevention of IgG-mediated complications in the peri-transplant periodDennis L Cooper, Jhannine Alyssa Verceles, Taba Kheradmand, et al.
Global Spine Journal|August 17, 2017
Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the SpineMichelle J Clarke, Camilo A Molina, Daryl R Fourney, et al.
Pageof 210